BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 24589281)

  • 41. Usefulness of Left Atrial Emptying Fraction to Predict Ventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillators.
    Rijnierse MT; Kamali Sadeghian M; Schuurmans Stekhoven S; Biesbroek PS; van der Lingen AC; van de Ven PM; van Rossum AC; Nijveldt R; Allaart CP
    Am J Cardiol; 2017 Jul; 120(2):243-250. PubMed ID: 28532781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel approach to restore atrial function after the maze procedure in patients with an enlarged left atrium.
    Marui A; Tambara K; Tadamura E; Saji Y; Sasahashi N; Ikeda T; Nishina T; Komeda M
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):308-12. PubMed ID: 17574430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Frequency and predictors of atrial fibrillation in severe mitral regurgitation].
    Duran NE; Duran I; Sönmez K; Gençbay M; Akçay A; Turan F
    Anadolu Kardiyol Derg; 2003 Jun; 3(2):129-34. PubMed ID: 12826507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Tani T; Tanabe K; Ono M; Yamaguchi K; Okada M; Sumida T; Konda T; Fujii Y; Kawai J; Yagi T; Sato M; Ibuki M; Katayama M; Tamita K; Yamabe K; Yamamuro A; Nagai K; Shiratori K; Morioka S
    J Am Soc Echocardiogr; 2004 Jun; 17(6):644-8. PubMed ID: 15163936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of atrial fibrillation ablation on left atrial function: association with baseline left atrial function.
    Masuda M; Inoue K; Iwakura K; Okamura A; Koyama Y; Kimura R; Toyoshima Y; Ito N; Komuro I; Fujii K
    Pacing Clin Electrophysiol; 2012 Mar; 35(3):327-34. PubMed ID: 22150125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Left Atrial Reverse Remodeling After Catheter Ablation of Nonparoxysmal Atrial Fibrillation in Patients With Heart Failure With Reduced Ejection Fraction.
    Oka T; Inoue K; Tanaka K; Ninomiya Y; Hirao Y; Tanaka N; Okada M; Inoue H; Nakamaru R; Koyama Y; Okamura A; Iwakura K; Sakata Y; Fujii K
    Am J Cardiol; 2018 Jul; 122(1):89-96. PubMed ID: 29703439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atrial Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Bourfiss M; van der Heijden JF; Loh P; Hauer RN; Tandri H; Calkins H; Nazarian S; Te Riele ASJM; Zimmerman SL; Velthuis BK
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007344. PubMed ID: 30354672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship Between Left Atrial Functional Measures and Incident Atrial Fibrillation in the General Population: The Copenhagen City Heart Study.
    Olsen FJ; Møgelvang R; Jensen GB; Jensen JS; Biering-Sørensen T
    JACC Cardiovasc Imaging; 2019 Jun; 12(6):981-989. PubMed ID: 29454773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of right atrial structure with incident atrial fibrillation: a longitudinal cohort cardiovascular magnetic resonance study from the Multi-Ethnic Study of Atherosclerosis (MESA).
    Xie E; Yu R; Ambale-Venkatesh B; Bakhshi H; Heckbert SR; Soliman EZ; Bluemke DA; Kawut SM; Wu CO; Nazarian S; Lima JAC
    J Cardiovasc Magn Reson; 2020 May; 22(1):36. PubMed ID: 32434529
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Impact of Left Atrial Minimal Volume on Clinical Outcome in Patients with Non-Obstructive Hypertrophic Cardiomyopathy.
    Shin SH; Jang JH; Baek YS; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
    Int Heart J; 2018 Sep; 59(5):991-995. PubMed ID: 30158386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors.
    Sciacqua A; Perticone M; Tripepi G; Miceli S; Tassone EJ; Grillo N; Carullo G; Sesti G; Perticone F
    Int J Cardiol; 2014 Jul; 175(1):90-5. PubMed ID: 24836687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of left atrial imaging in the management of atrial fibrillation.
    Walters TE; Ellims AH; Kalman JM
    Prog Cardiovasc Dis; 2015; 58(2):136-51. PubMed ID: 26241303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors and Mechanisms of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Raphael CE; Liew AC; Mitchell F; Kanaganayagam GS; Di Pietro E; Newsome S; Owen R; Gregson J; Cooper R; Amin FR; Gatehouse P; Vassiliou V; Ernst S; O'Hanlon R; Frenneaux M; Pennell DJ; Prasad SK
    Am J Cardiol; 2020 Dec; 136():140-148. PubMed ID: 32950468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do the left atrial substrate properties correlate with the left atrial mechanical function? A novel insight from the electromechanical study in patients with atrial fibrillation.
    Sung SH; Chang SL; Hsu TL; Yu WC; Tai CT; Lin YJ; Lo LW; Wongcharoen W; Tuan TC; Hu YF; Udyavar A; Chen SA
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):165-71. PubMed ID: 17916141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Left atrial dyssynchrony assessed by strain imaging in predicting future development of atrial fibrillation in patients with heart failure.
    Cho GY; Jo SH; Kim MK; Kim HS; Park WJ; Choi YJ; Hong KS; Oh DJ; Rhim CY
    Int J Cardiol; 2009 May; 134(3):336-41. PubMed ID: 18804876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kwapiszewska A; Kukula K; Jamiolkowski J; Dabrowski M; Derejko P; Oreziak A; Baranowski R; Spiewak M; Marczak M; Klisiewicz A; Szepietowska B; Chmielak Z; Witkowski A
    Clin Cardiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30120784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association Between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical Substrate and NT-proANP Levels in Atrial Fibrillation.
    Seewöster T; Büttner P; Nedios S; Sommer P; Dagres N; Schumacher K; Bollmann A; Hilbert S; Jahnke C; Paetsch I; Hindricks G; Kornej J
    J Am Heart Assoc; 2018 Oct; 7(19):e009427. PubMed ID: 30371296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion.
    Therkelsen SK; Groenning BA; Svendsen JH; Jensen GB
    Am J Cardiol; 2006 Apr; 97(8):1213-9. PubMed ID: 16616028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.